azathioprine has been researched along with Pemphigoid in 62 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the safety and efficacy of oral methylprednisolone combined with azathioprine sodium or mycophenolate mofetil for the treatment of bullous pemphigoid." | 9.12 | A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. ( Beissert, S; Böhm, M; Bonsmann, G; Frieling, U; Gollnick, H; Hunzelmann, N; Junghans, V; Luger, TA; Meurer, M; Pillekamp, H; Ruzicka, T; Rzany, B; Stadler, R; Sticherling, M; Werfel, T; Zillikens, D, 2007) |
| "We conclude that neither azathioprine nor plasma exchange is effective enough to be used routinely as an adjuvant to corticosteroids in the management of bullous pemphigoid." | 9.07 | Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. ( Bernard, P; Foldès-Pauwels, C; Guillaume, JC; Guillot, B; Joly, P; Labeille, B; Picard, C; Prigent, F; Prost, C; Vaillant, L, 1993) |
| "Current treatment of bullous pemphigoid (BP) is based on the long-term use of topical and/or systemic corticosteroids, which are associated with a high rate of adverse events and increased mortality." | 6.84 | An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone. ( Aberer, E; Franke, A; Gläser, R; Hertl, M; Pfeiffer, C; Rzany, B; Schmidt, E; Schneider, S; Shimanovich, I; Sticherling, M; Werfel, T; Wilczek, A; Zillikens, D, 2017) |
| "Clobetasol propionate cream applied over the whole body is probably similarly effective as, and may cause less mortality than, oral prednisone for treating bullous pemphigoid." | 5.41 | Interventions for bullous pemphigoid. ( Anchan, VN; Boyle, RJ; Chi, CC; Kirtschig, G; Murrell, DF; Singh, S; Taghipour, K, 2023) |
| "To investigate the safety and efficacy of oral methylprednisolone combined with azathioprine sodium or mycophenolate mofetil for the treatment of bullous pemphigoid." | 5.12 | A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. ( Beissert, S; Böhm, M; Bonsmann, G; Frieling, U; Gollnick, H; Hunzelmann, N; Junghans, V; Luger, TA; Meurer, M; Pillekamp, H; Ruzicka, T; Rzany, B; Stadler, R; Sticherling, M; Werfel, T; Zillikens, D, 2007) |
| "We conclude that neither azathioprine nor plasma exchange is effective enough to be used routinely as an adjuvant to corticosteroids in the management of bullous pemphigoid." | 5.07 | Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. ( Bernard, P; Foldès-Pauwels, C; Guillaume, JC; Guillot, B; Joly, P; Labeille, B; Picard, C; Prigent, F; Prost, C; Vaillant, L, 1993) |
| "Preliminary data suggest a possible association between the use of azathioprine, cyclophosphamide, and cyclosporine and increased susceptibility to cancer in patients with pemphigus and pemphigoid." | 4.86 | Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid. ( Ahmed, AR; Christen, WG; Gürcan, HM; Keskin, DB; Mabrouk, D, 2010) |
| "Azathioprine has an important role in treatment of many inflammatory dermatoses." | 3.69 | Azathioprine in dermatology: a survey of current practice in the U.K. ( English, JS; Gawkrodger, DJ; Lear, JT; Tan, BB, 1997) |
| " We report two cases where multifocal Kaposi's sarcoma developed following iatrogenic immunosuppression with prednisolone and azathioprine for bullous pemphigoid." | 3.69 | Kaposi's sarcoma associated with immunosuppression for bullous pemphigoid. ( Cerio, R; Halpern, SM; Kirby, JT; Parslew, R; Sharpe, GR, 1997) |
| "Severe cases of pemphigus vulgaris should be treated with prednisone in high dosage (180-360 mg daily)." | 3.67 | [Therapy of pemphigus and pemphigoid]. ( Schaumburg-Lever, G, 1986) |
| "Current treatment of bullous pemphigoid (BP) is based on the long-term use of topical and/or systemic corticosteroids, which are associated with a high rate of adverse events and increased mortality." | 2.84 | An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone. ( Aberer, E; Franke, A; Gläser, R; Hertl, M; Pfeiffer, C; Rzany, B; Schmidt, E; Schneider, S; Shimanovich, I; Sticherling, M; Werfel, T; Wilczek, A; Zillikens, D, 2017) |
| "Bullous pemphigoid is the most common autoimmune bullous disease in the West." | 2.43 | Interventions for bullous pemphigoid. ( Hollis, S; Khumalo, N; Kirtschig, G; Middleton, P; Murrell, D; Wojnarowska, F, 2005) |
| "Bullous pemphigoid is an autoimmune skin blistering disorder that can present with several different degrees of severity." | 2.43 | Bullous pemphigoid treatment review. ( Korman, NJ; Patton, T, 2006) |
| "Bullous pemphigoid is the most common autoimmune bullous disease in the West." | 2.42 | Interventions for bullous pemphigoid. ( Hollis, S; Khumalo, N; Kirtschig, G; Middleton, P; Murrell, D; Wojnarowska, F, 2003) |
| "Azathioprine has been available for 30 years and is used in a variety of dermatologic conditions." | 2.38 | Azathioprine in dermatology. ( Colver, GB; Harris, DW; Younger, IR, 1991) |
| "Bullous pemphigoid is a rare, autoimmune blistering disease." | 1.38 | "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin. ( Filipe, P; Lopes, L; Marques, MS; Pacheco, D; Soares-Almeida, L, 2012) |
| "Several variants of bullous pemphigoid have been reported including pemphigoid nodularis." | 1.37 | Pemphigoid nodularis: a case report. ( Kalaaji, AN; Lehman, JS; Rogers, RS; Stone, RA, 2011) |
| "Bullous pemphigoid is the most frequent autoimmune blistering skin disease." | 1.31 | [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. ( Géniaux, M; Marcet, B; Sibaud, V; Taieb, A, 2002) |
| " All patients went into remission with a lower daily dosage of oral prednisone at 3 and 6 months postplasmapheresis." | 1.31 | Plasmapheresis as a steroid saving procedure in bullous pemphigoid. ( Egan, CA; Meadows, KP; Zone, JJ, 2000) |
| "We describe the clinical presentation, treatment of Kaposi's sarcoma skin lesions in an immunosuppressed patient with bullous pemphigoid." | 1.30 | Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid. ( Gaspari, AA; Marchese, S; Powell, D; Rady, PL; Tyring, SK, 1997) |
| "Bullous pemphigoid is a clinically heterogeneous disease although little is known of the factors affecting its course and outcome." | 1.28 | Lack of predictive factors for the clinical course of bullous pemphigoid. ( Venning, VA; Wojnarowska, F, 1992) |
| "Bullous pemphigoid is an autoimmune bullous dermatosis that can be preceded by a prodromal phase, usually lasting weeks to months, during which the cutaneous changes are dermatitic rather than bullous." | 1.27 | The prodrome of bullous pemphigoid. ( Amato, DA; Silverstein, J; Zitelli, J, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (17.74) | 18.7374 |
| 1990's | 13 (20.97) | 18.2507 |
| 2000's | 19 (30.65) | 29.6817 |
| 2010's | 15 (24.19) | 24.3611 |
| 2020's | 4 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Yaïci, R | 1 |
| Roth, M | 1 |
| Juergens, L | 1 |
| Nawaiseh, SA | 1 |
| Burkhard, D | 1 |
| Besgen, V | 1 |
| Fuest, M | 1 |
| Girbardt, C | 1 |
| Hampel, U | 1 |
| Heichel, J | 1 |
| Heiligenhaus, A | 1 |
| Herwig-Carl, MC | 1 |
| Kakkassery, V | 1 |
| Kontopoulou, K | 1 |
| Löffler, KU | 1 |
| Maier, PC | 1 |
| Nölle, B | 1 |
| Pach, J | 1 |
| Paul, S | 1 |
| Pleyer, U | 1 |
| Pöllmann, M | 1 |
| Saeger, M | 1 |
| Schmidt, E | 4 |
| Siebelmann, S | 1 |
| Sokolenko, E | 1 |
| Strudel, L | 1 |
| Stübiger, N | 1 |
| Tarhan, M | 1 |
| Theuersbacher, J | 1 |
| van Oterendorp, C | 1 |
| Walker, M | 1 |
| Wiecha, C | 1 |
| Wykrota, AA | 1 |
| Geerling, G | 1 |
| Hsieh, CY | 1 |
| Tsai, TF | 1 |
| Singh, S | 1 |
| Kirtschig, G | 5 |
| Anchan, VN | 1 |
| Chi, CC | 1 |
| Taghipour, K | 1 |
| Boyle, RJ | 1 |
| Murrell, DF | 4 |
| Holtsche, MM | 1 |
| Hammers, CM | 1 |
| Chakievska, L | 1 |
| Ludwig, RJ | 1 |
| Thaci, D | 1 |
| Zillikens, D | 4 |
| Sticherling, M | 2 |
| Franke, A | 1 |
| Aberer, E | 1 |
| Gläser, R | 1 |
| Hertl, M | 1 |
| Pfeiffer, C | 1 |
| Rzany, B | 2 |
| Schneider, S | 1 |
| Shimanovich, I | 1 |
| Werfel, T | 2 |
| Wilczek, A | 1 |
| Kakuta, R | 1 |
| Yamagami, J | 1 |
| Funakoshi, T | 1 |
| Takahashi, H | 1 |
| Ohyama, M | 1 |
| Amagai, M | 1 |
| Patsatsi, A | 1 |
| Kyriakou, A | 1 |
| Werth, VP | 1 |
| Cruz, MJ | 1 |
| Santos, P | 1 |
| Morais, P | 1 |
| Barreto, F | 1 |
| Azevedo, F | 1 |
| Imbernón-Moya, A | 1 |
| Aguilar, A | 1 |
| Burgos, F | 1 |
| Gallego, MÁ | 1 |
| Yamashita, C | 1 |
| Nakamizo, S | 1 |
| Honda, Y | 1 |
| Dainichi, T | 1 |
| Kabashima, K | 1 |
| Bystryn, JC | 1 |
| Recke, A | 1 |
| Rose, C | 1 |
| Bröcker, EB | 1 |
| Sitaru, C | 1 |
| Mabrouk, D | 1 |
| Gürcan, HM | 1 |
| Keskin, DB | 1 |
| Christen, WG | 1 |
| Ahmed, AR | 2 |
| Middleton, P | 3 |
| Bennett, C | 1 |
| Wojnarowska, F | 5 |
| Khumalo, NP | 2 |
| Kusajima, E | 1 |
| Akiyama, M | 1 |
| Sato, M | 1 |
| Natsuga, K | 1 |
| Shimizu, H | 1 |
| Bernard, P | 2 |
| Charneux, J | 1 |
| Daniel, BS | 1 |
| Borradori, L | 1 |
| Hall, RP | 1 |
| Guilabert, A | 1 |
| Lozano, F | 1 |
| Iranzo, P | 1 |
| Suárez-Casasús, B | 1 |
| Martinez-De Pablo, I | 1 |
| Julià, M | 1 |
| Mascaró, JM | 1 |
| Lehman, JS | 1 |
| Kalaaji, AN | 1 |
| Rogers, RS | 1 |
| Stone, RA | 1 |
| Nigam, R | 1 |
| Levitt, J | 1 |
| Pacheco, D | 1 |
| Lopes, L | 1 |
| Soares-Almeida, L | 1 |
| Marques, MS | 1 |
| Filipe, P | 1 |
| Zachariae, CO | 1 |
| Marcet, B | 1 |
| Sibaud, V | 1 |
| Géniaux, M | 1 |
| Taieb, A | 1 |
| Erbagci, Z | 1 |
| Khumalo, N | 2 |
| Hollis, S | 2 |
| Murrell, D | 2 |
| Burnett, PE | 1 |
| Sakuma-Oyama, Y | 1 |
| Powell, AM | 1 |
| Albert, S | 1 |
| Oyama, N | 1 |
| Bhogal, BS | 1 |
| Black, MM | 1 |
| Kreuter, A | 1 |
| Harati, A | 1 |
| Breuckmann, F | 1 |
| Appelhans, C | 1 |
| Altmeyer, P | 1 |
| Hofmann, SC | 1 |
| Bruckner-Tuderman, L | 1 |
| Patton, T | 1 |
| Korman, NJ | 1 |
| Beissert, S | 1 |
| Frieling, U | 1 |
| Böhm, M | 1 |
| Stadler, R | 1 |
| Hunzelmann, N | 1 |
| Meurer, M | 1 |
| Gollnick, H | 1 |
| Ruzicka, T | 1 |
| Pillekamp, H | 1 |
| Junghans, V | 1 |
| Bonsmann, G | 1 |
| Luger, TA | 1 |
| Leonard, N | 1 |
| Biswas, A | 1 |
| Hickey, S | 1 |
| Bell, H | 1 |
| Montag, H | 1 |
| Gendler, E | 1 |
| Levene, GM | 1 |
| Olmos, L | 1 |
| de Diego, V | 1 |
| Foster, CS | 1 |
| Wilson, LA | 1 |
| Ekins, MB | 1 |
| Jones, JJ | 1 |
| Ashworth, J | 1 |
| Anstey, A | 1 |
| Guillaume, JC | 1 |
| Vaillant, L | 1 |
| Picard, C | 1 |
| Prost, C | 1 |
| Labeille, B | 1 |
| Guillot, B | 1 |
| Foldès-Pauwels, C | 1 |
| Prigent, F | 1 |
| Joly, P | 1 |
| Tan, BB | 1 |
| Lear, JT | 1 |
| Gawkrodger, DJ | 1 |
| English, JS | 1 |
| Krunic, AL | 1 |
| Kokai, D | 1 |
| Bacetic, B | 1 |
| Kesic, V | 1 |
| Nikolic, MM | 1 |
| Petkovic, S | 1 |
| Clark, RE | 1 |
| Halpern, SM | 1 |
| Parslew, R | 1 |
| Cerio, R | 1 |
| Kirby, JT | 1 |
| Sharpe, GR | 1 |
| Gaspari, AA | 1 |
| Marchese, S | 1 |
| Powell, D | 1 |
| Rady, PL | 1 |
| Tyring, SK | 1 |
| Primka, EJ | 1 |
| Camisa, C | 1 |
| Tavadia, SM | 1 |
| Mydlarski, PR | 1 |
| Reis, MD | 1 |
| Mittmann, N | 1 |
| Pinkerton, PH | 1 |
| Shear, N | 1 |
| Sauder, DN | 1 |
| Egan, CA | 2 |
| Meadows, KP | 1 |
| Zone, JJ | 1 |
| Yancey, KB | 1 |
| Burgess, MJ | 1 |
| Fivenson, DP | 1 |
| Goulon, M | 1 |
| Combes, A | 1 |
| Chesneau, AM | 1 |
| Bournérias, I | 1 |
| Yamada, H | 1 |
| Ogawa, H | 1 |
| Venning, VA | 1 |
| Younger, IR | 1 |
| Harris, DW | 1 |
| Colver, GB | 1 |
| Rupprecht, M | 1 |
| Stäbler, A | 1 |
| Hornstein, OP | 1 |
| Collison, DW | 1 |
| Dahlberg, PJ | 1 |
| Hogan, JD | 1 |
| Bandemir, W | 1 |
| Krëger, E | 1 |
| Prasad, KK | 1 |
| Chen, L | 1 |
| Jeffes, EW | 1 |
| Amato, DA | 1 |
| Silverstein, J | 1 |
| Zitelli, J | 1 |
| Schaumburg-Lever, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid: A Randomized Controlled Trial[NCT05984381] | Phase 4 | 62 participants (Anticipated) | Interventional | 2023-08-01 | Recruiting | ||
| An Open Randomized Comparative Trial of Four Different Dressings for Cutaneous Coverage in Pemphigus and Pemphigoid[NCT02365675] | 12 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | |||
| A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Bullous Pemphigoid[NCT00431119] | Phase 2 | 70 participants | Interventional | 1997-10-31 | Completed | ||
| Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325] | Phase 1/Phase 2 | 8 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | B cells per microliter (Median) |
|---|---|
| Treated | 3.99 |
IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | Elisa Units (Median) |
|---|---|
| Treated | 40.5 |
The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year
| Intervention | Days (Median) |
|---|---|
| Treated | 57 |
Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks
| Intervention | participants (Number) |
|---|---|
| Treated | 7 |
The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year
| Intervention | participants (Number) | ||
|---|---|---|---|
| Treatment emergent adverse events | Infusion reactions | Disease Progression | |
| Treated | 0 | 0 | 1 |
16 reviews available for azathioprine and Pemphigoid
| Article | Year |
|---|---|
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.
Topics: Acitretin; Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Biological Factors; Biologi | 2022 |
Interventions for bullous pemphigoid.
Topics: Azathioprine; Clobetasol; Dapsone; Doxycycline; Humans; Methylprednisolone; Niacinamide; Pemphigoid, | 2023 |
Bullous pemphigoid in adolescence.
Topics: Adolescent; Anti-Infective Agents; Azathioprine; Child; Dapsone; Female; Glucocorticoids; Humans; Im | 2019 |
Erythema Multiforme-Like Bullous Pemphigoid.
Topics: Adult; Autoantibodies; Autoantigens; Azathioprine; Biopsy; Collagen Type XVII; Diagnosis, Differenti | 2016 |
Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Biomarkers; Biopsy, Needle; Combined Mo | 2009 |
Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Neoplasms; Pemphigoi | 2010 |
Interventions for bullous pemphigoid.
Topics: Azathioprine; Clobetasol; Combined Modality Therapy; Drug Therapy, Combination; Drugs, Chinese Herba | 2010 |
[Bullous pemphigoid: a review].
Topics: Aged; Azathioprine; Clobetasol; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug | 2011 |
Evidence-based management of bullous pemphigoid.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Autoantibodies; Azathioprine; Clinical Trials as Top | 2011 |
Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Glucocorticoids; Humans; Immunologic Factors; | 2012 |
Interventions for bullous pemphigoid.
Topics: Azathioprine; Glucocorticoids; Humans; Immunosuppressive Agents; Niacinamide; Pemphigoid, Bullous; P | 2003 |
Interventions for bullous pemphigoid.
Topics: Azathioprine; Glucocorticoids; Humans; Immunosuppressive Agents; Niacinamide; Pemphigoid, Bullous; P | 2005 |
Bullous pemphigoid treatment review.
Topics: Administration, Topical; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Cyclophosph | 2006 |
The treatment of pemphigus and pemphigoid.
Topics: Aged; Azathioprine; Cosyntropin; Drug Therapy, Combination; Humans; Methylprednisolone; Pemphigoid, | 1982 |
A systematic review of treatments for bullous pemphigoid.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; | 2002 |
A systematic review of treatments for bullous pemphigoid.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; | 2002 |
A systematic review of treatments for bullous pemphigoid.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; | 2002 |
A systematic review of treatments for bullous pemphigoid.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; | 2002 |
Azathioprine in dermatology.
Topics: Azathioprine; Drug Interactions; Eczema; Humans; Leukopenia; Pemphigoid, Bullous; Pemphigus; Skin Di | 1991 |
4 trials available for azathioprine and Pemphigoid
| Article | Year |
|---|---|
An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Azathioprine; Dapsone; Dermatologic Agents; Dru | 2017 |
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Azathioprine; Dose-Response | 2007 |
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.
Topics: Azathioprine; Combined Modality Therapy; Humans; Methyltransferases; Pemphigoid, Bullous; Plasma Exc | 1993 |
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.
Topics: Aged; Azathioprine; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Pemp | 1993 |
42 other studies available for azathioprine and Pemphigoid
| Article | Year |
|---|---|
On the Current Care Situation and Treatment of Ocular Mucous Membrane Pemphigoid in Germany.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Mucous Membrane; Pemphigoid, Benign Mucous Membrane; | 2023 |
Adjuvant treatment with secukinumab induced long term remission in a patient with severe bullous pemphigoid.
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal, Humanized; Azathioprine; Humans; Pemphigoid, Bullous | 2020 |
Azathioprine monotherapy in autoimmune blistering diseases: A feasible option for mild to moderate cases.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Feasibility Studies; Female; Humans; Immunosuppressive | 2018 |
Refractory bullous pemphigoid with fatal outcome in a young patient.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Drug Resistan | 2013 |
Combination therapy of prednisolone and i.v. immunoglobulin treatment decreases circulating interleukin-5 and eosinophils in a patient with bullous pemphigoid.
Topics: Administration, Intravenous; Autoantibodies; Autoantigens; Azathioprine; Biopsy; Collagen Type XVII; | 2017 |
Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Pemphigoid, Bullous; Randomized C | 2008 |
Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Azathioprine; Cohort Studies; Collagen | 2011 |
A case of aggressive bullous pemphigoid associated with the defective functional variant of Fc gamma receptor IIb: implications for pathogenesis?
Topics: Aged; Alleles; Autoantibodies; Autoantigens; Azathioprine; Collagen Type XVII; Cyclophosphamide; Dap | 2011 |
Pemphigoid nodularis: a case report.
Topics: Aged; Antimetabolites; Azathioprine; Diagnosis, Differential; Female; Fluorescent Antibody Technique | 2011 |
"Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
Topics: Azathioprine; Blister; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; M | 2012 |
Gabapentin-induced bullous pemphigoid.
Topics: Acetates; Amines; Anticonvulsants; Azathioprine; Cyclohexanecarboxylic Acids; Drug Therapy, Combinat | 2002 |
[Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?].
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Dermatologic Ag | 2002 |
Childhood bullous pemphigoid following hepatitis B immunization.
Topics: Adrenal Cortex Hormones; Azathioprine; Biopsy, Needle; Child; Drug Therapy, Combination; Female; Fol | 2002 |
Bullous pemphigoid and psoriasis vulgaris.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Male; Middle Aged; Pemphigoid, Bullous; Psoriasis | 2003 |
Lichen planus pemphigoides evolving into pemphigoid nodularis.
Topics: Autoantigens; Azathioprine; Carrier Proteins; Collagen Type XVII; Cytoskeletal Proteins; Dystonin; E | 2003 |
Intravenous immune globulin in the treatment of persistent pemphigoid gestationis.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immuno | 2004 |
[Bullous pemphigoid: diagnostics and new therapeutic strategies].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biopsy | 2006 |
Eosinophilic spongiosis in a case of lichen sclerosus: a marker for superimposed bullous pemphigoid?
Topics: Aged; Azathioprine; Drug Therapy, Combination; Eosinophilia; Female; Glucocorticoids; Humans; Immuno | 2008 |
[Azathioprine and its side effects].
Topics: Aged; Azathioprine; Gastrectomy; Hepatic Encephalopathy; Humans; Jaundice; Male; Methylprednisolone; | 1984 |
Azathioprine for use in dermatology.
Topics: Azathioprine; Behcet Syndrome; Humans; Pemphigoid, Bullous; Pemphigus; Pityriasis Rubra Pilaris; Pso | 1984 |
[Psoriasis and pemphigoid (author's transl)].
Topics: Adult; Aged; Azathioprine; Female; Humans; Male; Methylprednisolone; Middle Aged; Pemphigoid, Bullou | 1981 |
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid.
Topics: Adult; Aged; Azathioprine; Cicatrix; Conjunctival Diseases; Corneal Diseases; Cyclophosphamide; Drug | 1982 |
Azathioprine-induced shock in dermatology patients.
Topics: Aged; Anaphylaxis; Azathioprine; Female; Humans; Male; Middle Aged; Pemphigoid, Bullous; Polyarterit | 1993 |
Azathioprine in dermatology: a survey of current practice in the U.K.
Topics: Azathioprine; Bone Marrow; Dermatitis, Atopic; Dermatology; Drug Administration Schedule; Health Car | 1997 |
Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption.
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Azathioprine; Diagnosis, Differential; Fe | 1997 |
Kaposi's sarcoma associated with immunosuppression for bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Azathioprine; Humans; Immunosuppressive Agents; Leg; Male; Pemphigoid, Bull | 1997 |
Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Azathioprine; DNA, Viral; Female; Herpesvirus 8, Human; Humans; Immunosuppr | 1997 |
Psoriasis and bullous pemphigoid treated with azathioprine.
Topics: Aged; Aged, 80 and over; Azathioprine; Basement Membrane; Complement C3c; Female; Fluorescent Antibo | 1998 |
Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.
Topics: Adult; Azathioprine; Costs and Cost Analysis; Female; Genetic Testing; Homozygote; Humans; Immunosup | 2000 |
Plasmapheresis as a steroid saving procedure in bullous pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoantigens; Azathioprine; Carrier Protei | 2000 |
Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations.
Topics: Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Basement Membrane; Female; Glucocortic | 2000 |
Generalization of cicatricial pemphigoid during azathioprine therapy.
Topics: Aged; Azathioprine; Cicatrix; Female; Humans; Immunosuppressive Agents; Pemphigoid, Bullous | 2000 |
[Polyradiculopathy associated with bullous pemphigoid (author's transl)].
Topics: Aged; Azathioprine; Dermatitis Herpetiformis; Diagnosis, Differential; Humans; Male; Pemphigoid, Bul | 1979 |
[Plasma exchange therapy of dermatosis].
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Betamethasone; Female; Humans; Middle Aged; Pemphigoid | 1992 |
Lack of predictive factors for the clinical course of bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Dapsone; Drug Therapy, Combination; Fema | 1992 |
[Genital mucous membrane manifestation of localized bullous pemphigoid].
Topics: Aged; Azathioprine; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Humans; Immun | 1991 |
Azathioprine hypersensitivity in bullous pemphigoid.
Topics: Aged; Azathioprine; Drug Hypersensitivity; Female; Fever; Headache; Humans; Pemphigoid, Bullous; Ski | 1990 |
[Therapeutic use of plasmapheresis in a patient with bullous pemphigoid].
Topics: Aged; Aged, 80 and over; Azathioprine; Humans; Male; Pemphigoid, Bullous; Plasmapheresis; Skin Disea | 1989 |
Anesthetic management of a patient with bullous pemphigoid.
Topics: Anesthesia, Spinal; Azathioprine; Female; Humans; Injections, Spinal; Middle Aged; Pemphigoid, Bullo | 1989 |
Adjuvant therapy of bullous pemphigoid with dapsone.
Topics: Adult; Aged; Azathioprine; Dapsone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pe | 1989 |
The prodrome of bullous pemphigoid.
Topics: Aged; Azathioprine; Biopsy; Dermatitis; Female; Fluorescent Antibody Technique; Humans; Middle Aged; | 1988 |
[Therapy of pemphigus and pemphigoid].
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Methotrexate; Pemphigoid, Bullous | 1986 |